Clinical Trial Update: Personalized Vaccine with SOC Chemo Followed by Nivo in Pancreatic Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating a personalized vaccine in combination with standard-of-care chemotherapy followed by nivolumab in pancreatic adenocarcinoma; the study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma

Drugs mentioned

• Personalized Vaccine
• nivolumab (nivolumab)

Snippet

Sponsor: Centre Hospitalier Universitaire Vaudois | Conditions: Pancreatic Adenocarcinoma | Phase 1 | Status: ACTIVE_NOT_RECRUITING